View in EDS HTML Full Text PDF Full Text

Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.

Saved in:
Bibliographic Details
Title: Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.
Authors: Cao, Jun1 (AUTHOR), Teng, Yuee2 (AUTHOR), Li, Huiping3 (AUTHOR), Zhang, Lili4 (AUTHOR), Ouyang, Quchang5 (AUTHOR), Xie, Weimin6 (AUTHOR), Pan, Yueyin7 (AUTHOR), Song, Zhenchuan8 (AUTHOR), Ling, Xiaoling9 (AUTHOR), Wu, Xiaohong10 (AUTHOR), Xu, Jingwei11 (AUTHOR), Li, Li12 (AUTHOR), Ren, Liping13 (AUTHOR), Wang, Hong14 (AUTHOR), Zhou, Dongxian15 (AUTHOR), Luo, Jing16 (AUTHOR), Hu, Xichun1 (AUTHOR) xchu2009@hotmail.com
Source: BMC Medicine. 8/9/2023, Vol. 21 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 169848680
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Cao%2C+Jun%22">Cao, Jun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Teng%2C+Yuee%22">Teng, Yuee</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Huiping%22">Li, Huiping</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Lili%22">Zhang, Lili</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ouyang%2C+Quchang%22">Ouyang, Quchang</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xie%2C+Weimin%22">Xie, Weimin</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Yueyin%22">Pan, Yueyin</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Song%2C+Zhenchuan%22">Song, Zhenchuan</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ling%2C+Xiaoling%22">Ling, Xiaoling</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Xiaohong%22">Wu, Xiaohong</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Jingwei%22">Xu, Jingwei</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Li%22">Li, Li</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ren%2C+Liping%22">Ren, Liping</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Hong%22">Wang, Hong</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Dongxian%22">Zhou, Dongxian</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Luo%2C+Jing%22">Luo, Jing</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Xichun%22">Hu, Xichun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> xchu2009@hotmail.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22BMC+Medicine%22">BMC Medicine</searchLink>. 8/9/2023, Vol. 21 Issue 1, p1-10. 10p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=169848680
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12916-023-02999-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 1
    Titles:
      – TitleFull: Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cao, Jun
      – PersonEntity:
          Name:
            NameFull: Teng, Yuee
      – PersonEntity:
          Name:
            NameFull: Li, Huiping
      – PersonEntity:
          Name:
            NameFull: Zhang, Lili
      – PersonEntity:
          Name:
            NameFull: Ouyang, Quchang
      – PersonEntity:
          Name:
            NameFull: Xie, Weimin
      – PersonEntity:
          Name:
            NameFull: Pan, Yueyin
      – PersonEntity:
          Name:
            NameFull: Song, Zhenchuan
      – PersonEntity:
          Name:
            NameFull: Ling, Xiaoling
      – PersonEntity:
          Name:
            NameFull: Wu, Xiaohong
      – PersonEntity:
          Name:
            NameFull: Xu, Jingwei
      – PersonEntity:
          Name:
            NameFull: Li, Li
      – PersonEntity:
          Name:
            NameFull: Ren, Liping
      – PersonEntity:
          Name:
            NameFull: Wang, Hong
      – PersonEntity:
          Name:
            NameFull: Zhou, Dongxian
      – PersonEntity:
          Name:
            NameFull: Luo, Jing
      – PersonEntity:
          Name:
            NameFull: Hu, Xichun
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 08
              Text: 8/9/2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 17417015
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC Medicine
              Type: main
ResultId 1